(R)-(1-(5-Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)methanol

ID: ALA4086173

PubChem CID: 129900195

Max Phase: Preclinical

Molecular Formula: C13H18N4O

Molecular Weight: 246.31

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1c[nH]c2ncnc(N3CCC[C@@H](CO)C3)c12

Standard InChI:  InChI=1S/C13H18N4O/c1-9-5-14-12-11(9)13(16-8-15-12)17-4-2-3-10(6-17)7-18/h5,8,10,18H,2-4,6-7H2,1H3,(H,14,15,16)/t10-/m1/s1

Standard InChI Key:  YDGQZYCXWPQCTM-SNVBAGLBSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   21.0899   -6.0573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7995   -5.6479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7967   -4.8252    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0881   -4.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3818   -5.6484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3785   -4.8319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6009   -4.5826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1236   -5.2452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6063   -5.9037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3453   -3.8065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0854   -3.6028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.7920   -3.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7913   -2.3850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0841   -1.9748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3759   -2.3845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3749   -3.2043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6682   -1.9758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9605   -2.3842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  7 10  1  0
  4 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  6
 17 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4086173

    ---

Associated Targets(Human)

KHK Tchem Ketohexokinase (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 246.31Molecular Weight (Monoisotopic): 246.1481AlogP: 1.48#Rotatable Bonds: 2
Polar Surface Area: 65.04Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.22CX LogP: 1.55CX LogD: 1.52
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.84Np Likeness Score: -0.82

References

1. Huard K, Ahn K, Amor P, Beebe DA, Borzilleri KA, Chrunyk BA, Coffey SB, Cong Y, Conn EL, Culp JS, Dowling MS, Gorgoglione MF, Gutierrez JA, Knafels JD, Lachapelle EA, Pandit J, Parris KD, Perez S, Pfefferkorn JA, Price DA, Raymer B, Ross TT, Shavnya A, Smith AC, Subashi TA, Tesz GJ, Thuma BA, Tu M, Weaver JD, Weng Y, Withka JM, Xing G, Magee TV..  (2017)  Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK).,  60  (18): [PMID:28853885] [10.1021/acs.jmedchem.7b00947]

Source